About Naslund Medical


Naslund Medical AB is a privately held medical products company focused on the improved management and care of patients receiving radiation therapy. As the pioneer and leader in developing new technology for fiducial markers, Naslund Medical AB markets Gold Anchor worldwide. Gold Anchor enables quicker and more effective radiation therapy treatment with increased patient safety. Naslund Medical AB is based in Sweden with subsidiaries in the U.S. and France and with contracted distributors on a global level.

The Gold Anchor has been invented and developed by Ingemar Naslund, M.D, Associate Professor, working as head of the Division of Radiation Therapy, Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden for 20 years. Dr. Naslund was also part of the first publication on the SBRT-technique that he invented with his colleagues Dr. Henrik Blomgren and Associate Professor Ingemar Lax. This technique has now spread all over the world and is becoming standard of care for some tumours.

Drawing knowledge from the fine needle aspiration cytology (also invented at Karolinska by Dr. Sixten Franzén) and the new technical development with on-board kV-imaging, Dr. Naslund had the idea that he could fit a very thin marker inside a very thin needle and thereby enabling safe fiducial based SBRT to organs all over the body. To our knowledge there is no other fiducial marker than Gold Anchor offering fiducial markers in ultrathin 25G needles. Learn more under Benefits.

Image from Varian Medical Systems Centerline Magazine, October 2004.

The inventor of Gold Anchor Dr. Ingemar Naslund (to the left) with two of his collegues from The Karolinska University Hospital in Stockholm, Sweden. They are standing in front of a Varian linear accelerator with onboard kV-imaging. Karolinska was one of the first in the world to install such a linear accelerator back in 2004.

The Karolinska University Hospital was ranked #6 best hospital in the world 2023 by Newsweek.


We are happy to announce that for the third year in a row we have been recognized as one of the fastest growing companies in Sweden, awarded with the DI Mästargasell prize!

Thank you, all Gold Anchor users and distributors! We have made great progress in improving radiotherapy treatments together.

Swecare Export Award 2019

Naslund Medical has been awarded 2019 year’s Swecare Export Award for its innovation power, strategy and strong exports. We are grateful, proud and happy to be part of improving cancer care throughout the world.

Link to Swecare Export Award 2019 (text in Swedish).

Partnership with academia & healthcare

Swedish Testbed for Innovative Radiotherapy

Naslund Medical is one of the partners in a consortium aiming at establishing a Swedish testbed for innovative radiotherapy. The testbed will allow healthcare and industry to test new technology and new methods in clinical settings – and jointly drive the development of cancer treatment with radiation therapy. Learn more >


Gentle Radiotherapy

Since all cancer treatment have adverse effects on the patient, we have to do it right the first time for every individual patient, this increases the chance of cure without harming the patient – “Gentle therapy”.

Naslund Medical is one of the business partners in a consortium consisting of all teaching hospitals associated with academia and 7 important industrial companies. The long-term goal is to create a large-scale national world class platform for cancer treatment.


Quality Management System

Naslund Medical AB is certified to SS-EN ISO 13485:2016.

mail sign

Subscribe to our newsletter

Do you want to keep updated about Gold Anchor? Product development, exhibitions, testimonials. Sign up for our newsletter.

By clicking Subscribe, you agree to that you have read our Privacy Policy including Cookies.